Haloperidol-Lurasidone

From Psychiatrienet
Revision as of 14:19, 5 March 2015 by Roland (talk | contribs) (Created page with '{{Drugswitch | from = Haloperidol | to = Lurasidon | stop = * '''Day 1-7:''' gradually reduce the dose of haloperidol to 50% of the dose. * '''Day 8-14:''' gradually reduce the...')
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Haloperidol
Type Antipsychotic
Group Butyrophenones
links
ATC-code N05AD01
Medscape Haloperidol
PubChem 3559
PubMed Haloperidol
Drugs.com haloperidol
Kompas (Dutch) Haloperidol
Wikipedia Haloperidol
Lurasidone
Type Antipsychotic
Group Atypical AP
links
Medscape Lurasidone
PubMed Lurasidone
Kompas (Dutch) Lurasidone
Wikipedia Lurasidone

Switch medication from Haloperidol to Lurasidon.

Nietinrijdenbord.png Stop Haloperidol
  • Day 1-7: gradually reduce the dose of haloperidol to 50% of the dose.
  • Day 8-14: gradually reduce the dose of haloperidol to 0% of the dose
  • Day 14: stop administration of haloperidol.
Eenrichtingbord.png Start Lurasidon
  • Day 1-7: start administration of lurasidon in a dose of 40 mg/day.
  • Day 8-14: increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.
Infobord.png More information
  • During this switch you could monitor ECG, especially in patients prone to QT-conduction problems.
  • There is a possibility of QT interval prolongation.[5]
  • It is also possible to start administration of lurasidon on day 1 in a dose of 80 mg/day. [6]
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.